IMUX
#3631
Immunic, Inc. - Common Stock
15.2 2 USD
+0.04%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+3.96%
Monthly Change
+9.03%
6 month change
+2138.24%
Year Change
+1690.59%
Previous Close
14.6 4
Open
15.3 8
Low
15.0 8
High
15.4 6
Volume
28
Financials
- Market Capitalization 207.32 M
- Employee 95
- Founded N/A
- CEO Daniel Vitt
- Website www.imux.com
- Headquarter Delaware, United States
- FIGI BBG001M75SX4
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.86
Price to sales ratio
-167.18
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3620 |  CDXS Codexis, Inc. - Common Stock | 2.19 USD | -2.67% | -16.73% | -11.69% | -29.13% | 199.06 M USD | ||
| 3628 |  NKTX Nkarta, Inc. - Common Stock | 2.76 USD | -1.08% | -22.47% | -7.69% | +46.03% | 197.47 M USD | ||
| 3639 |  NERV Minerva Neurosciences, Inc - Common Stock | 4.16 USD | -2.58% | -15.10% | -9.76% | +136.36% | 193.81 M USD | ||
| 3642 |  VYGR Voyager Therapeutics, Inc. - Common Stock | 3.23 USD | -0.31% | -15.00% | -9.01% | -30.54% | 195.16 M USD |
Frequently asked questions about Immunic, Inc. - Common Stock
What is the Immunic, Inc. - Common Stock stock price today?
The current price of Immunic, Inc. - Common Stock (IMUX) is 15.22. Over the past 24 hours, the stock has changed by +3.96%. Follow the IMUX chart for real-time price dynamics.
What is the stock ticker of Immunic, Inc. - Common Stock?
Immunic, Inc. - Common Stock trades under the ticker IMUX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Immunic, Inc. - Common Stock stock going up?
IMUX has changed by -1.55% over the last week, +9.03% over the last month, and +1690.59% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Immunic, Inc. - Common Stock net income for the last quarter?
Immunic, Inc. - Common Stock reported net income of -32.59 M for the last quarter. The previous quarter showed -19.3 M, which means net income changed by -68.85%.
How many employees does Immunic, Inc. - Common Stock have?
As of the latest available data, Immunic, Inc. - Common Stock has 95 employees. Workforce size can provide additional context about the company's scale and operations.
What is Immunic, Inc. - Common Stock EBITDA?
Immunic, Inc. - Common Stock EBITDA is -33.5 M, and its EBITDA margin is 22.19 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Immunic, Inc. - Common Stock stock?
You can buy Immunic, Inc. - Common Stock (IMUX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Immunic, Inc. - Common Stock stock?
Investing in Immunic, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMUX chart and related analysis on metatrader.com as part of your research.